Dr. Saul Hertz and The Origin of Nuclear Medicine
November 18, 2014–February 1, 2015
Medical radioisotope use to treat cancer has its origins in 1936 when Dr. Hertz spontaneously asked the President of MIT Karl Compton, "Could iodine be made radioactive artificially?" This exhibit on Dr. Hertz's work and legacy is on loan from Barbara Hertz, curator of the Saul Hertz Archives.
Today, the Isotope Production Facility of the Los Alamos Neutron Science Center at Los Alamos National Laboratory is a global leader in producing and researching novel radioisotopes to target malignancies.
Dr. Saul Hertz using a multicounter to analyze the distribution of radioactive iodine in a patient in early 1941.
Thursday, November 20, 5:30 PM; @ the Manhattan Project Restaurant
Jon Engle, a Los Alamos National Laboratory postdoc researcher, will talk about the Laboratory’s isotope program and their efforts to make medically useful radioisotopes. Uses of these fall into two categories generally: diagnostic and therapeutic. Diagnostic technologies are fairly mature in nuclear medicine and as such they do a great deal of good out in the clinic. Treating disease with radioisotopes is not a very new idea, but success in humans is. The field is dynamic and progressing rapidly thanks to several new technologies that the Laboratory plays a role in developing alongside many other entities in the international community.
The “On Tap” series happens every Thursday evening starting at 5:30 PM, with science on the third Thursday of every month. Other weeks include topics on nature, art, and history. Join us!
This series begins each evening with an informal 10 to 15-minute lecture followed by a lively group discussion. “On Tap” is a way for people to get out and about in the community, learn something new, and meet people with similar interests.
November newsletter now available
Find out what's happening @ the Bradbury Science Museum in our monthly newsletter. Sign up for our mailing list to get an emailed copy.